Unlike endogenous -MSH, which degrades within seconds via enzymatic cleavage, MT-1's modified structure resists degradation by serum proteases, allowing sustained melanocortin receptor activation across multiple tissue types
More than 17,000 adults Overweight or obesity (body mass index 27 or higher) Established cardiovascular disease (such as prior heart attack, stroke, or peripheral artery disease) No diabetes This was mostly a secondary prevention populationpeople who already had cardiovascular disease
Hong, Y., He, H., Jiang, C., et al
Side Effects: MT1 is associated with relatively mild side effects, including localized adverse reactions, nausea, facial flushing, and tiredness [10]
J Reprod Med 1997;42:153156
It renders greater physical strength, enhances stamina, and increases the sex drive